The Cancer Genomics Consortium invites you to attend a webinar, Accelerating Precision Oncology: Real-time genomic and epigenomic profiling with Oxford Nanopore, sponsored by Oxford Nanopore Technologies on Friday, June 12, 2026.
This webinar highlights how real-time Oxford Nanopore sequencing is transforming precision oncology through rapid genomic and epigenomic profiling. Dr. Parth S. Shah (Geisel School of Medicine at Dartmouth) will present his approach to accelerating the diagnosis and molecular characterization of hematologic malignancies using nanopore sequencing. Dr. Bastiaan Tops (Princess Maxima Center) will showcase a rapid, methylation-based classification workflow for CNS tumors.
Join us to hear how rapid molecular insights can be leveraged to inform clinical decision-making and advance time-critical cancer care.
Speakers:
Parth Shah, Director of Genome Informatics, Geisel School of Medicine at Dartmouth
Bastiaan B.J. Tops, Head of Laboratory of Childhood Cancer Pathology at Princess Máxima Center
Oxford Nanopore Technologies products are RUO.
Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in-vitro diagnostic devices in some jurisdictions, please check individual product labelling.
Oxford Nanopore Technologies present the materials of third parties within the user community acknowledging that those materials belong to and are the true statements and representations of those third parties. Oxford Nanopore Technologies make no endorsements of the materials shown and the statements made.